Physician profile
Qingwu Kong
NPI 1760912372
$22,979.48
in general payments reported to CMS, 2019-2025
19 companies · $2,547 in 2025
The $2,547 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $746 · 2021: $4,040 · 2022: $3,227 · 2023: $7,127 · 2024: $4,510 · 2025: $2,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,245 · Food and Beverage: $6,893 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,245.07 |
| Food and Beverage | $6,892.91 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,436.32 | 2022-2025 | Mako, Aequalis Ascend Flex, Triathlon |
| Zimmer Biomet Holdings, INC. | $9,026.52 | 2019-2024 | Persona, Oxford, G7 |
| Medical Device Business Services, INC. | $1,788.83 | 2021-2022 | |
| Depuy Synthes Sales INC. | $478.95 | 2022-2023 | Attune, Na |
| Smith+Nephew, INC. | $189.85 | 2022-2025 | Pico 7 |
| Cerapedics INC. | $176.71 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Seaspine Orthopedics Corporation | $140.65 | 2019 | |
| Integra Lifesciences Corporation | $139.86 | 2019 | |
| Globus Medical, INC. | $117.55 | 2019 | |
| Nuvasive Specialized Orthopedics, INC. | $112.91 | 2019 | |
| Si-Bone, INC. | $99.46 | 2019 | |
| Axogen | $60.18 | 2022 | |
| Camber Spine Technologies LLC | $57.11 | 2019 | |
| Curonix LLC | $32.79 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ferring Pharmaceuticals INC. | $32.54 | 2025 | Euflexxa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $30.54 | 2024 | Painteq |
| Innovation Technologies INC | $21.32 | 2024 | Irrisept |
| Saluda Medical Americas, INC. | $20.19 | 2025 | Evoke |
| Boston Scientific Corporation | $17.20 | 2025 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qingwu Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.